APA (7th ed.) Citation

SJ, N., AJ, N., M, D., JJP, K., CM, B., KK, R., . . . MH, D. (2026). Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial. Nature medicine, 32(5), 1935. https://doi.org/10.1038/s41591-026-04405-7

Chicago Style (17th ed.) Citation

SJ, Nicholls, et al. "Author Correction: Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia: The BROOKLYN Randomized Clinical Trial." Nature Medicine 32, no. 5 (2026): 1935. https://doi.org/10.1038/s41591-026-04405-7.

MLA (9th ed.) Citation

SJ, Nicholls, et al. "Author Correction: Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia: The BROOKLYN Randomized Clinical Trial." Nature Medicine, vol. 32, no. 5, 2026, p. 1935, https://doi.org/10.1038/s41591-026-04405-7.